Algernon Pharmaceuticals Inc. C.AGN

Price Drop

[nodaytrader]

On Friday, AGN announced promising results from a study on treatment of Chronic Kidney Didease.
On the very next trading day, we have a slew of mini trades that knock millions off the company's capital value. 

what is going on? Are any of the regulators, who are supposed to guard investor interests, liking into this? Have they even noticed?

[C10H12N2]

What millions? The company has had a trash valuation since the flop of the COVID-19 results. If anything, the company remains overvalued. It has less than 1M USD on hand and no uplist timeline. You'll be lucky if they simply don't go bankrupt at this point with clueless management at the helm.

[nodaytrader]

Thursday's closing price was $4.60 - it is now $4.00. With almost 1.7 million shares that's over a million dollars in a little more than a day. And that is a continuation of a steep drop in recent days. But this steep decline, like all of the others in the last couple of years, is not characterized by a rush to the exit - trading volumes have been low, but by a succession of mini

[C10H12N2]

It's just the ebb and flow of a trash stock. Instead of looking at a micro view look at it from a view at 30000 feet here. https://stockhouse.com/companies/peers?symbol=c.agn The scale between Algernon and the others tells the story without going off on a wild tangent that will not produce a single investigation. If investigations were actually a thing at CSE Algernon would likely have been

[C10H12N2]

One other point. Do you remember Christopher Moreau not long ago telling the market Algernon has traded over a billion shares since becoming Algernon Pharmaceuticals? How many of those trades were shares of less than a 100 share lot? I've seen scores of trades below 100 shares. It's all Smoke & Mirrors. Best of Luck